Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-048508

Chief Financial Officer bought 2,500 shares at $5.91 ($14,775)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-08-11 Purchase : show line 1 in the form +2,500 $5.91 $14,775 339,410 D
Open-market purchases · 2,500 sh · avg $5.91 · $14,775
Loading xslF345X03/doc4.xml…